Literature DB >> 26782733

Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.

V Sreeja1, Jashbhai B Prajapati2.   

Abstract

The use of probiotics is a new way to control and treat infections in this modern era. Application of beneficial bacteria to protect against detrimental bacteria in the gastrointestinal tract and thus reap a positive health benefit is the basis of probiotic therapy. Probiotics have a long global history of traditional use. They are normally consumed through fermented foods and are currently sold mostly as ingredients in foods or nutritional supplements. They are also supplied as pharma products. Recent research has highlighted the probiotic potential in the treatment or prevention of disease conditions, maintenance of health, improving immunity and in the reduction in the risk of future diseases. But their position in the pharmaceutical industry is still not very clear. Clinical practitioners use probiotic pharma products mostly as supplements. Their status as drugs is still unclear. This review is aimed to analyze probiotics as pharmaceuticals, their current status as dietary supplements and drugs, existing probiotic preparations and future research needs.

Entities:  

Keywords:  Pharmaceuticals; Probiotic preparations; Probiotic therapy; Probiotics; Regulations

Year:  2013        PMID: 26782733     DOI: 10.1007/s12602-013-9126-2

Source DB:  PubMed          Journal:  Probiotics Antimicrob Proteins        ISSN: 1867-1306            Impact factor:   4.609


  60 in total

Review 1.  Probiotics as biotherapeutic agents: present knowledge and future prospects.

Authors:  A Mercenier; S Pavan; B Pot
Journal:  Curr Pharm Des       Date:  2003       Impact factor: 3.116

Review 2.  Probiotics: time for a dose of realism.

Authors:  Gerald W Tannock
Journal:  Curr Issues Intest Microbiol       Date:  2003-09

3.  The design of probiotic studies to substantiate health claims.

Authors:  Glenn R Gibson; Robert J Brummer; Erika Isolauri; Herbert Lochs; Lorenzo Morelli; Theo Ockhuizen; Ian R Rowland; Jürgen Schrezenmeir; Catherine Stanton; Kristin Verbeke
Journal:  Gut Microbes       Date:  2011-09-01

Review 4.  Probiotics and their fermented food products are beneficial for health.

Authors:  S Parvez; K A Malik; S Ah Kang; H-Y Kim
Journal:  J Appl Microbiol       Date:  2006-06       Impact factor: 3.772

5.  Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.

Authors:  Giuliano Rizzardini; Dorte Eskesen; Philip C Calder; Amedeo Capetti; Lillian Jespersen; Mario Clerici
Journal:  Br J Nutr       Date:  2011-09-07       Impact factor: 3.718

6.  Effect of Lactobacillus strains and Saccharomyces boulardii on persistent diarrhea in children.

Authors:  David Gaón; Hugo García; Luis Winter; Nora Rodríguez; Ricardo Quintás; Silvia N González; Guillermo Oliver
Journal:  Medicina (B Aires)       Date:  2003       Impact factor: 0.653

7.  Acidified milk formula supplemented with bifidobacterium lactis: impact on infant diarrhea in residential care settings.

Authors:  Jean-Pierre Chouraqui; Louis-Dominique Van Egroo; Marie-Claire Fichot
Journal:  J Pediatr Gastroenterol Nutr       Date:  2004-03       Impact factor: 2.839

8.  Long-term consumption of infant formulas containing live probiotic bacteria: tolerance and safety.

Authors:  Jose M Saavedra; Adel Abi-Hanna; Nancy Moore; Robert H Yolken
Journal:  Am J Clin Nutr       Date:  2004-02       Impact factor: 7.045

9.  Colon-targeted delivery of live bacterial cell biotherapeutics including microencapsulated live bacterial cells.

Authors:  Satya Prakash; Aleksandra Malgorzata Urbanska
Journal:  Biologics       Date:  2008-09

Review 10.  Probiotics: considerations for human health.

Authors:  Mary Ellen Sanders
Journal:  Nutr Rev       Date:  2003-03       Impact factor: 7.110

View more
  6 in total

Review 1.  Probiotics in human health and disease: from nutribiotics to pharmabiotics.

Authors:  Eun-Sook Lee; Eun-Ji Song; Young-Do Nam; So-Young Lee
Journal:  J Microbiol       Date:  2018-10-24       Impact factor: 3.422

2.  Protein-bound uremic toxin lowering strategies in chronic kidney disease: a systematic review and meta-analysis.

Authors:  Kullaya Takkavatakarn; Thunyatorn Wuttiputinun; Jeerath Phannajit; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Paweena Susantitaphong
Journal:  J Nephrol       Date:  2021-01-23       Impact factor: 3.902

3.  Thermophysical Fingerprinting of Probiotic-Based Products.

Authors:  Hary Razafindralambo; Aurélie Razafindralambo; Christophe Blecker
Journal:  Sci Rep       Date:  2019-07-10       Impact factor: 4.379

Review 4.  Gastrointestinal Disorders and Metabolic Syndrome: Dysbiosis as a Key Link and Common Bioactive Dietary Components Useful for their Treatment.

Authors:  Anna De Filippis; Hammad Ullah; Alessandra Baldi; Marco Dacrema; Cristina Esposito; Emanuele Ugo Garzarella; Cristina Santarcangelo; Ariyawan Tantipongpiradet; Maria Daglia
Journal:  Int J Mol Sci       Date:  2020-07-13       Impact factor: 5.923

Review 5.  Gut health benefit and application of postbiotics in animal production.

Authors:  Yifan Zhong; Shanshan Wang; Hanqiu Di; Zhaoxi Deng; Jianxin Liu; Haifeng Wang
Journal:  J Anim Sci Biotechnol       Date:  2022-04-08

6.  Bulk and Surface Wettability Characteristics of Probiotic Powders in Their Compressed Disc and Packed-Bed Column Forms.

Authors:  Mohamed A Ali; Hary L Razafindralambo; Giuseppina Conti; Joël De Coninck
Journal:  ACS Omega       Date:  2020-08-28
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.